MedTrace Logo

Cognition Assessment and REhabilitation in Virtual Reality for Patients With Cancer

NCT07335393 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-01-13

No results posted yet for this study

Summary

1. To assess the cognitive function of patients with cancer by leveraging a validated virtual reality (VR)-based cognitive assessment tool.
2. To evaluate the efficacy of VR-based cognitive rehabilitation therapy (VR-CRT) compared to a control group in improving cognitive functions in cancer patients.

Hypothesis

Cancer patients with cancer-related cognitive impairment who receive the VR-CRT program will demonstrate significantly greater improvement in cognitive functions, as measured by the validated VR cognition assessment tool, compared to those who receive standard care, both immediately post-intervention and at 3-month follow-up.

Conditions

  • Patients With Cancer

Interventions

BEHAVIORAL

VR-based cognitive rehabilitation therapy (VR-CRT)

12 VR-CRT sessions over 4 weeks, with sessions occurring 3 times per week, targeting attention, memory, and executive function

Sponsors & Collaborators

Principal Investigators

  • Yingchun Zeng · National University of Singapore

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2027-12-31
Completion
2027-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07335393 on ClinicalTrials.gov